Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-02-11 | 2021-03-25 | 133782 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2024-02-08 | 2024-04-05 | 218960 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-04-03 | 2017-10-24 | 5180 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-01 | 136329 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2020-03-26 | 2021-01-28 | 109562 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2023-08-18 | 2023-10-04 | 202490 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2024-05-30 | 2025-02-21 | 229230 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2025-01-09 | 2025-02-20 | 247319 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-09-17 | 2020-12-17 | 124471 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-08-27 | 2020-09-25 | 123084 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Actual shortage | 2025-05-02 | 2025-05-08 | 256447 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-08-20 | 2020-12-17 | 122693 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2024-06-27 | 2024-08-08 | 231421 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195867 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-07-20 | 2023-10-04 | 199313 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2020-05-01 | 2020-06-11 | 113788 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-05-01 | 2020-06-04 | 113776 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2022-08-18 | 2025-04-25 | 167162 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |